Pre/Post-Surgery Support.

EPA displaces arachidonic acid in platelet membranes and shifts eicosanoid output toward the less aggregatory thromboxane A3. Stacked with other platelet-modifying ingredients in the same formula the effect on normal clotting is additive.

Ginkgolide B antagonises the platelet-activating factor receptor, so platelets aggregate less readily. Combined with fish oil, garlic or high-dose vitamin E the effects on normal clotting add together.

Allicin-derived organosulfur compounds inhibit platelet aggregation and thromboxane formation. That effect adds to any other platelet-modifying ingredient carried in the same formula.

Alpha-tocopherol quinone metabolites interfere with vitamin K-dependent gamma-carboxylation of clotting factors, and tocopherol also dampens platelet aggregation. At high intake this works against normal clotting and adds to other platelet-active ingredients.

Vitamin K is the cofactor for gamma-carboxylation of prothrombin and factors VII, IX and X, the exact step high-dose vitamin E interferes with. The two pull in opposite directions on normal clotting factor activation.

Nattokinase is a serine protease that degrades fibrin directly and raises endogenous plasminogen activator output. Layered onto platelet-modifying ingredients it adds a second, separate effect on normal clot handling.

Bromelain hydrolyses fibrin and bradykinin peptides, which is why it appears in swelling and tissue recovery formulas. The same fibrinolytic action adds to other ingredients that alter normal clotting.

Ascorbate is the reducing cofactor for prolyl and lysyl hydroxylase, the enzymes that hydroxylate collagen chains so a stable triple helix can form. It is the standard partner for zinc and dietary protein in tissue repair formulas.

Zinc is a structural or catalytic cofactor for DNA and RNA polymerases and for matrix metalloproteinases involved in normal tissue remodelling. It pairs with vitamin C and protein in recovery formulas.

Arginine is the substrate for nitric oxide synthase and, through ornithine, for proline and polyamine synthesis in new tissue. It is the anchor of the long-standing arginine plus glutamine plus HMB recovery combination.

Glutamine is the preferred fuel for enterocytes and rapidly dividing immune cells and a nitrogen donor for nucleotide synthesis. It is paired with arginine and HMB in recovery formulas for this reason.

HMB is a leucine metabolite that lowers proteasome-mediated protein breakdown while arginine and glutamine supply substrate. The three are formulated together because they act at different points of the same nitrogen balance.

Juven is the packaged arginine plus glutamine plus HMB combination, so it duplicates those ingredients rather than adding a separate mechanism. Formulating both means the same amino acids are counted twice.

Collagen peptides supply the glycine, proline and hydroxyproline the body incorporates into new connective tissue, and vitamin C supplies the hydroxylation step. Substrate without the cofactor leaves the helix poorly crosslinked.

Whey delivers the full essential amino acid set, with leucine driving mTOR-mediated protein synthesis, which is what the vitamin C and zinc cofactors act upon. Cofactors without adequate protein have little substrate to work with.

Hyperforin activates the pregnane X receptor, which induces CYP3A4 and intestinal P-glycoprotein. Anything co-formulated that depends on those routes for clearance sees its exposure shift, which is textbook pharmacology rather than a nutrient interaction.

Kavalactones modulate GABA-A channels and sodium channel gating, producing sedation. Stacked with valerian, melatonin or other GABAergic ingredients the sedative effect adds together.

Valerenic acid acts at the GABA-A receptor beta subunit and slows GABA breakdown. That effect adds to kava, melatonin and other calming ingredients in the same formula.

Gingerols inhibit thromboxane synthase and reduce platelet aggregation at higher intakes. The effect is modest alone and matters mainly as an addition to fish oil, garlic or ginkgo in the same formula.

Iron and zinc both move through DMT1 at the enterocyte brush border, so a large iron dose in the same serving lowers zinc uptake. Separating them keeps the zinc that repair enzymes rely on available.

Retinoic acid drives the transcription programme for keratinocyte and epithelial differentiation, the layer that closes over new tissue. It complements the vitamin C and zinc pair rather than duplicating it.

Perioperative bowel preparation, fasting and antibiotics reshape the colonic community, and defined strains are studied as a way to reintroduce fermentative organisms during that window. The review examines microbiota modulation as a strategy in colorectal procedures rather than establishing a single protocol. Read it as mechanistic support with clinical work still in progress.

Because it is a yeast, it survives concurrent antibacterial therapy that would suppress lactobacilli and bifidobacteria. That makes it the organism most often paired with perioperative antibiotic exposure in the literature. It does not colonise, so effects track dosing and stop when dosing stops.

Wound-support protocols often carry zinc at levels well above ordinary intake, and weeks of that pattern lower copper uptake through metallothionein induction. Copper is itself required for lysyl oxidase, the enzyme that cross-links collagen. Anyone running an extended high-zinc window has a reason to keep copper in view.

Every third residue in collagen is glycine, so tissue repair draws heavily on it. Dietary protein and collagen peptides supply it, and free glycine is the simplest direct source. This is substrate provision, not a claim about the speed of any repair.

Proline is the substrate that vitamin C dependent hydroxylation acts on, which is why the two are usually discussed together. Without hydroxylation the triple helix is unstable at body temperature. The pairing supports normal connective tissue formation as a substrate-and-cofactor pair.

Procedures that reduce gastric acid output or bypass part of the stomach cut both the release step and the intrinsic factor supply. That is why B12 status is monitored in this setting and why parenteral or high-dose oral routes are used. The pharmacology is settled and does not depend on a combination trial.

Body stores last weeks rather than months, so a period of low intake or vomiting depletes them quickly. Thiamine pyrophosphate is the cofactor for pyruvate dehydrogenase and transketolase, both central to carbohydrate handling. Refeeding after a low-intake window raises demand at exactly the point stores are lowest.

When acid output is reduced by medication or by an altered anatomy, the carbonate salt dissolves poorly while the citrate salt stays soluble across a wider pH range. This is a formulation matching question rather than a ranking of the salts. It matters most when calcium is being taken alongside vitamin D for normal bone maintenance.

Any change in fat digestion, whether from reduced fat intake, altered bile flow or a shortened absorptive segment, lowers the fraction of an oral vitamin D dose taken up. Vitamin D in turn governs active calcium absorption. The two travel together for that reason.

Osteocalcin has to be gamma-carboxylated before it binds calcium in bone matrix, and vitamin K is the cofactor for that step. Blends built around calcium and vitamin D often add K2 on this basis. MK-7 has a long circulating half-life relative to K1, which is why it appears in once-daily products.

Selenoenzymes handle peroxide load, and their activity is limited by selenium supply. Perioperative nutrition products commonly carry it alongside zinc and vitamin C for that reason. The relationship is cofactor availability, not a claim about recovery speed.

Iron binding restricts free luminal iron that gut bacteria would otherwise use, which is the basis of the iron-handling interest in this protein. It has also been examined as an iron delivery form that is less dependent on ferrous transport. Human work in the perioperative setting is limited, so hold this as mechanism.

Protein intake is the main driver of nitrogen balance during a repair window, and the slow release profile of casein complements a fast whey dose across the day. Total daily protein matters more than any single source. The pairing is about distribution over hours, not about one protein being better than another.

ATP is biologically active as a magnesium complex, so magnesium supply sits underneath every energy-requiring step of tissue repair. It also affects parathyroid hormone secretion and therefore calcium handling. Intake often falls during periods of reduced eating.

Rapidly dividing tissue needs nucleotides, and nucleotide synthesis runs on folate-carried one-carbon units. Folate and B12 are interdependent, since B12 releases folate from the methyl trap. Anyone supplementing one over a long window has a reason to keep the other in the picture.

Dectin-1 binding is a defined receptor interaction and is why yeast glucans appear in perioperative nutrition formulas. The receptor biology is established; the clinical translation in this specific setting is not. Read it as mechanistic rather than clinical.

Sleep disruption is common around a hospital stay, and melatonin is the most studied non-prescription option for phase shifting. Stacked with other sedating supplements or medication the drowsiness adds up. That additivity is the reason to flag the pairing rather than assume it is neutral.

Oral arginine is largely degraded before it reaches the circulation, while citrulline is converted to arginine in the kidney. Arginine is the substrate for nitric oxide synthase and feeds the urea and proline pathways. Where an arginine-based protocol is in use, citrulline is the pharmacokinetically different route to the same amino acid.

When carbohydrate intake resumes, the intracellular shift can drop serum phosphate quickly, and phosphate is required for ATP and 2,3-DPG. This is a monitored clinical situation rather than a supplement decision. It is listed here so the electrolyte interaction is visible rather than hidden.

Where fat digestion is reduced, less lipolysis means fewer mixed micelles and lower uptake of fat-soluble vitamins from the same meal. Lipase-containing products are used to address the digestion step rather than the vitamin dose. Enteric coating matters because gastric acid inactivates uncoated lipase.